跳至主要内容
临床试验/NCT01242319
NCT01242319已完成不适用

Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice

Memorial Hospital of Rhode Island1 个研究点 分布在 1 个国家目标入组 5,218 人开始时间: 2002年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,218
试验地点
1
主要终点
%patients at ATP III goals

研究概览

简要总结

This quality improvement trial aims to evaluate whether giving patients information about their coronary heart disease risk via a computer kiosk in the doctors waiting room and providing primary care doctors with a personal digital device with a decision support tool to help with cholesterol management will improve cholesterol management compared to usual care.

详细描述

This project will demonstrate and evaluate the translation of the ATP III Cholesterol management guidelines into primary care practice. During phase I, a needs assessment will evaluate barriers and facilitators to implementation of ATP III guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from semi-structured individual interviews of patients and providers and participant observation during pilot testing in 6 primary care practices, three tools will be refined and tailored: a computerized patient activation tool based upon NHLBI web-based 10-year CHD risk score that will be placed in each primary care office's waiting room for patient use; an ATP III interactive guidelines tool for hand held device (PDA) to be used by primary care providers as a decision support tool at the point of care and academic detailing materials consisting of a practice manual, interactive, PowerPoint slides, and practice materials to be used during an academic detailing session. During phase 2, a block, randomized designed cluster trial will be performed with one year of intervention within primary care practices (30 practices/55 providers) throughout the state of Rhode Island and Southeastern New England to test the effectiveness of the materials developed in phase I to improve physician performance around ATP III guideline implementation and to improve clinically relevant outcomes, the percentage of patients with LDL-cholesterol at their ATP III goal. Products for dissemination from this grant will include the results of the focus groups barriers and facilitators to implementation of ATP III guidelines findings, a Medical Abstraction tool for quality of care assessment regarding ATP III guidelines, a refined computerized patient activation tool, a tailored ATP III interactive guideline tool for the PDA, tailored academic detailing materials and results of the randomized clinical trial on the effectiveness of these tools to improve primary care practice.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Practices- within 50 miles of research unit,primary care providers, had at least 20 patients agreeing to have chart audited, agreed to be randomly allocated to the intervention or control.
  • Patients- age 18-80,expected to survive for at least 2 years,agreed to have limited chart audits -

排除标准

  • Practices- specialty practices not primary care, more than 50 miles away, involved in another cholesterol management trial, anticipating closing in the next two years.
  • Patients- children or adolescents,over the age of 80, dementia,comfort measures only.

结局指标

主要结局

%patients at ATP III goals

时间窗: one year after intervention

* of patients screened with lipid profiles * patients at LDL goal * patients at non-HDL goals

次要结局

  • Use on intervention tools(one year)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验